With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

The pharma will work with Triana Biomedicines on molecular glue degraders. Elsewhere, Akeso raised $250 million and a MASH ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

Goldman Sachs senior biotechnology analyst in global investment research Chris Shibutani joins Market Domination Hosts Julie ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

Pharma companies also are known for paying dividends, offering you a guaranteed stream of annual revenue. Below are three ...

When Sanofi announced last week that it plans to sell a 50% controlling stake of Opella, its consumer helath business, the ...

Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market.